Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Johnson and Johnson
Merck
Harvard Business School
Mallinckrodt

Last Updated: March 21, 2023

Details for New Drug Application (NDA): 018044


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 018044 describes ROCALTROL, which is a drug marketed by Validus Pharms and is included in two NDAs. It is available from two suppliers. Additional details are available on the ROCALTROL profile page.

The generic ingredient in ROCALTROL is calcitriol. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
Summary for 018044
Tradename:ROCALTROL
Applicant:Validus Pharms
Ingredient:calcitriol
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018044
Suppliers and Packaging for NDA: 018044
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROCALTROL calcitriol CAPSULE;ORAL 018044 NDA AUTHORIZED GENERIC Aphena Pharma Solutions - Tennessee, LLC 43353-138 43353-138-09 9000 CAPSULE in 1 BOTTLE (43353-138-09)
ROCALTROL calcitriol CAPSULE;ORAL 018044 NDA AUTHORIZED GENERIC Aphena Pharma Solutions - Tennessee, LLC 43353-138 43353-138-30 30 CAPSULE in 1 BOTTLE (43353-138-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.25MCG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.5MCG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 018044

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
AstraZeneca
Dow
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.